Explore the Potential with AI-Driven Innovation
The focused library is created on demand with the latest virtual screening and parameter assessment technology, supported by the Receptor.AI drug discovery platform. This method is more effective than traditional methods and results in higher-quality compounds with better activity, selectivity, and safety.
From a virtual chemical space containing more than 60 billion molecules, we precisely choose certain compounds. Our collaborator, Reaxense, aids in their synthesis and provision.
The library includes a list of the most effective modulators, each annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Furthermore, each compound is shown with its optimal docking poses, affinity scores, and activity scores, offering a detailed summary.
We use our state-of-the-art dedicated workflow for designing focused libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
The procedure entails thorough molecular simulations of the catalytic and allosteric binding pockets, accompanied by ensemble virtual screening that factors in their conformational flexibility. When developing modulators, the structural modifications brought about by reaction intermediates are factored in to optimize activity and selectivity.
Our library is unique due to several crucial aspects:
partner
Reaxense
upacc
O15392
UPID:
BIRC5_HUMAN
Alternative names:
Apoptosis inhibitor 4; Apoptosis inhibitor survivin
Alternative UPACC:
O15392; A2SUH6; B2R4R1; Q2I3N8; Q4VGX0; Q53F61; Q5MGC6; Q6FHL2; Q75SP2; Q9P2W8
Background:
Baculoviral IAP repeat-containing protein 5, also known as Apoptosis inhibitor survivin, plays a pivotal role in cell cycle regulation by promoting cell proliferation and inhibiting apoptosis. It is a key component of the chromosome passage protein complex, essential for chromosome alignment and segregation during mitosis and cytokinesis. This protein also contributes to mitotic spindle formation and maintains mitochondrial integrity and function.
Therapeutic significance:
Understanding the role of Baculoviral IAP repeat-containing protein 5 could open doors to potential therapeutic strategies. Its involvement in cell proliferation and apoptosis prevention highlights its potential as a target in cancer therapy, where regulation of these processes is often disrupted.